Company Overview
Natural Alternatives International, Inc. engages in the formulation, manufacturing, and marketing of nutritional supplements, serving both domestic and international markets through two primary operational segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. The company operates within the Consumer Defensive sector, specifically the Packaged Foods industry, which suggests a business model focused on providing essential goods that typically exhibit lower sensitivity to economic downturns compared to discretionary consumer products. As of the latest available data, the company possesses a market capitalization of $17.23M and reported annual revenue of $135.16M over the trailing twelve months, supported by an employee base of 293 individuals. These financial figures indicate that the company maintains a small-cap status, reflecting a niche market position within the broader nutritional supplement landscape where revenue generation is significant relative to its total market value.
Financial Health
The company reported revenue of $135.16M for the trailing twelve months, yet it recorded a net income of -$12,246,000, revealing a substantial gap between top-line revenue and bottom-line profitability that points to significant operating expenses or one-time charges affecting the cost structure. Despite these losses, the company generated EBITDA of $424,000, indicating that while accounting profits are currently negative, the core operational cash earnings before interest, taxes, depreciation, and amortization remain positive at a modest level. Free cash flow stands at $108,500, which provides a degree of financial flexibility to fund operations and potentially service debt obligations without relying solely on external financing. Profitability metrics further illustrate the financial pressure, with a gross margin of 9.1%, an operating margin of 7.9%, and a negative profit margin of -9.1%, suggesting that while production costs are controlled relative to sales, other overheads are consuming the majority of operating income. Liquidity and leverage are defined by a cash balance of $32.13M against total debt of $16.48M, resulting in a debt-to-equity ratio of 20.58, which suggests a balance sheet that is leveraged but maintains a conservative cash position relative to its obligations. Short-term liquidity appears robust with a current ratio of 1.87, indicating that current assets are more than double current liabilities and providing a comfortable buffer against short-term solvency risks. Return metrics highlight the impact of the loss on equity, with a return on equity of -16.8% and a return on assets of -1.7%, which reveals that management effectiveness in generating returns on the shareholder's capital and the total asset base is currently negative.
Valuation Assessment
Valuation metrics present a mixed picture, as the trailing P/E and forward P/E are both listed as N/A, implying that the absence of positive earnings prevents the use of traditional earnings-based valuation multiples. The price-to-book ratio is 0.25, which indicates that the market values the company at a fraction of its book value, suggesting a significant discount to the net asset value rather than a market premium. Alternative valuation multiples provide context, with a price-to-sales ratio of 0.13 and an EV/EBITDA of 2.58, suggesting the stock is priced at a low multiple of its sales and enterprise earnings, which often characterizes companies in turnaround situations or those with cyclical revenue profiles. The stock has traded between a 52-week high of $4.96 and a 52-week low of $2.33, and without a specific current price provided in the facts, the valuation context is strictly limited to these established trading bounds which define the range of investor sentiment. The beta value is 0.40, which indicates that the stock's price volatility is less than half that of the broader market, signifying a lower sensitivity to general market movements and offering a profile of reduced systematic risk for risk-averse portfolios.
Growth & Income
Growth dynamics show a revenue growth rate of 26.5% year-over-year coupled with an earnings growth rate of 74.1% year-over-year, indicating that earnings are growing significantly faster than revenue, which often implies improving operational leverage or a reduction in cost of goods sold relative to sales volume. The company does not distribute dividends to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests all available earnings into business growth, research, or debt reduction rather than providing income distributions. The overall growth and income profile is characterized by aggressive top-line expansion and a complete absence of dividend payouts, positioning the company as a capital-reinvestment play rather than an income-generating asset.